Ionis Pharmaceuticals (IONS) PT Raised to $82 at RBC Capital
Tweet
Share
E-mailGet Alerts IONS Hot Sheet
Price: $58.19 +1.66%
Rating Summary:
18 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Rating Summary:
18 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Join SI Premium – FREE
RBC Capital analyst Luca Issi raised the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $82.00 (from $80.00) while maintaining a rating.
You May Also Be Interested In
- JPMorgan Upgrades Hyundai Marine and Fire Insurance (001450:KS) to Neutral
- Ashok Leyland Ltd. (AL:IN) PT Raised to INR194 at Nomura/Instinet
- LG Electronics India (LGEL:IN) PT Raised to INR1,983 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
